Allows pharmaceutical companies to communicate off-label treatment uses to health care professionals

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 2 Compare versions History 12 Sponsors

No summary has been published for this bill. The full text is on the Bill text tab.

Chamber: House
Introduced: Dec 6, 2017
Last action: Apr 26, 2018 — Reported Do Pass (H) - AYES: 8 NOES: 0 PRESENT: 0
Session: 2018
Momentum: 44 · Moderate

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base Reported from Committee — base rate 2%, measured from MO's completed sessions
Momentum -1 44/100 from the pace of recorded action
Time since last action -22 3091 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.